Company: BNBX
Filing Date: 2025-01-10
Form Type: S-1/A
Source: 0001104659-25-002521
Chunk: 14

Company: BNB PLUS CORP.
Filing Date: 2025-01-10
Form: S-1/A
Chunk 14
---
SDOH and the FDA. The Company believes that ADCL will be able to support New York and other states’ response
to the threat of Mpox. ADCL’s Linea Mpox Virus 1.0 Assay was previously approved as a laboratory-developed test for the detection
of Mpox Clade II by NYSDOH in September 2022. In August 2024, ADCL conducted additional validation testing showing the Assay
can also detect the genetic sequence of Mpox Clade I, which is the subject of the World Health Organization’s (WHO) August 14,
2024 declaration of a public health emergency of international concern. ADCL will provide the testing service from its CLEP/CLIA molecular
diagnostics laboratory in Stony Brook, N.Y. There can be no assurance that we will be able to generate revenue and profits from Mpox
testing.

Historically, the majority of our revenue attributable
to our MDx Testing Services has been derived from our safeCircle® COVID-19 testing solutions, for which testing demand has significantly
declined commencing in our fiscal third quarter of 2023, resulting in substantially reduced revenues. We expect future demand for COVID-19
testing to continue to be reduced and we may terminate COVID-19 testing services in the future.

DNA Tagging and Security Products and Services

By leveraging our expertise in both the
manufacture and detection of DNA via PCR, our DNA Tagging and Security Products and Services allow our customers to use non-biologic
DNA tags manufactured on our LineaDNA platform to mark objects in a unique manner and then identify these objects by detecting the
absence or presence of the DNA tag. The Company’s core DNA Tagging and Security Products and Services, which are currently
marketed collectively as a platform under the trademark CertainT®, include:

| · | SigNature® Molecular Tags,                                                                         
 which are short non-biologic DNA taggants produced by the Company’s LineaDNA platform, provide     
 a methodology to authenticate goods within large and complex supply chains with a focus on cotton, 
 nutraceuticals and other products.                                                                 |

| · | SigNify® portable DNA                                                                                                         
 readers and SigNify consumable reagent test kits provide definitive real-time authentication of the Company’s DNA tags in the 
 field.                                                                                                                        |

| · | fiberTyping® and other                                                                                                       
 product genotyping services use PCR-based DNA detection to determine a cotton species or cultivar,